ABSTRACT
Sideline medical care is typically provided by musculoskeletal specialists and orthopaedic surgeons with varying levels of training and experience. While the most common sports injuries are often benign, the potential for catastrophic injury is omnipresent. Prompt recognition of sideline emergencies and expeditious medical management are necessary to minimize the risk of calamitous events. Paramount to successful sideline coverage are both preseason and game-day preparations. Because the skillset needed for the sideline physician may involve management of injuries not commonly seen in everyday clinical practice, sideline providers should review basic life support protocols, spine boarding, and equipment removal related to their sport(s) before the season begins. Before every game, the medical bag should be adequately stocked, location of the automatic external defibrillator/emergency medical services identified, and introductions to the trainers, coaches, and referees made. In addition to musculoskeletal injuries, the sideline orthopaedic surgeon must also be acquainted with the full spectrum of nonmusculoskeletal emergencies spanning the cardiopulmonary, central nervous, and integumentary systems. Familiarity with anaphylaxis as well as abdominal and neck trauma is also critical. Prompt identification of potential life-threatening conditions, carefully orchestrated treatment, and the athlete's subsequent disposition are essential for the team physician to provide quality care.
Subject(s)
Athletic Injuries , Emergencies , Emergency Medical Services , Humans , Athletic Injuries/therapy , Anaphylaxis/therapy , Anaphylaxis/etiology , Sports Medicine , Musculoskeletal System/injuriesABSTRACT
PURPOSE OF REVIEW: This review will identify and summarize the published existing data pertaining specifically to Hymenoptera venom allergy in children and adolescents, highlighting the major studies currently available on venom immunotherapy (VIT) and its prognosis in children. RECENT FINDINGS: The current review covers the incidence and prevalence of Hymenoptera venom allergy (HVA) in children, factors influencing occurrence and severity of reactions (age, sex, comorbidities, etc.), indications to perform diagnostic tests and start VIT in children, different existing VIT protocols and their safety and efficacy. SUMMARY: Hymenoptera venom allergy is the second most common cause of anaphylaxis in children and it considerably affects quality of life. Cutaneous reactions are the most prevalent clinical presentation in children who usually have a more favourable prognosis than adult patients. However, studies on HVA in children and adolescents are still limited. Currently VIT is the only treatment able to modify the natural history of HVA in adults as well as in children, and to protect patients from systemic reactions after subsequent stings.
Subject(s)
Anaphylaxis , Arthropod Venoms , Desensitization, Immunologic , Hymenoptera , Insect Bites and Stings , Humans , Child , Adolescent , Animals , Hymenoptera/immunology , Desensitization, Immunologic/methods , Arthropod Venoms/immunology , Arthropod Venoms/adverse effects , Insect Bites and Stings/immunology , Insect Bites and Stings/therapy , Insect Bites and Stings/epidemiology , Insect Bites and Stings/diagnosis , Anaphylaxis/epidemiology , Anaphylaxis/immunology , Anaphylaxis/prevention & control , Anaphylaxis/diagnosis , Anaphylaxis/etiology , Anaphylaxis/therapy , Hypersensitivity/immunology , Hypersensitivity/therapy , Hypersensitivity/epidemiology , Hypersensitivity/diagnosis , Allergens/immunology , Incidence , Prevalence , Quality of LifeABSTRACT
Allergy is a medical condition of frequent occurrence. In the Netherlands approximately 20% of the population has some kind of respiratory allergy, due to pollen and dust mites. The occurrence of allergy on foods, antibiotics, other medications, contrast fluid and insect poison is estimated to be 2% in the adult population. Because of this large and diverse group of allergy triggers it is very likely that physicians, regardless of background or medical specialty, will come across questions regarding allergy at some point in their career. The severity of an allergic reaction can vary, with anaphylaxis as one of the most severe and potentially life-threatening reactions (among DRESS, SJS, TEN and acute FPIES). This article describes the backgrounds of IgE-mediated allergy and anaphylaxis, like pathophysiology, diagnostics and treatment.
Subject(s)
Anaphylaxis , Humans , Anaphylaxis/diagnosis , Anaphylaxis/etiology , Anaphylaxis/therapy , Hypersensitivity/diagnosis , Immunoglobulin E/blood , Severity of Illness IndexABSTRACT
Idiopathic anaphylaxis (IA) remains a frustrating challenge for both patients and physicians. The aim of this paper is to focus on IA in pediatric ages and suggest possible diagnostic algorithms according to specific age ranges (infants, children, and adolescents). In fact, in a variable percentage of patients, despite extensive diagnostic tests, the cause of anaphylactic episodes cannot be identified. Moreover, the lack of a unanimous IA definition requires a careful and detailed diagnostic workup. Prompt recognition of signs and symptoms, especially in younger children, and an accurate clinical history often allow a choice of the most appropriate diagnostic tests and a correct differential diagnosis.
Subject(s)
Anaphylaxis , Humans , Anaphylaxis/diagnosis , Anaphylaxis/therapy , Anaphylaxis/etiology , Anaphylaxis/drug therapy , Child , Adolescent , Infant , Diagnosis, Differential , Child, Preschool , AlgorithmsABSTRACT
PURPOSE OF REVIEW: This review aims to identify phenotypes at-risk of Hymenoptera venom-induced anaphylaxis (HVA), focusing on different perspectives (epidemiological, clinical, and therapeutic) in order to adapt future preventive strategies. RECENT FINDINGS: HVA remains one of the leading causes of anaphylaxis, with a broad pattern of symptoms. Although most cases occur outside healthcare settings, data indicate a high emergency admission rate due to insect stings. Mortality is often underestimated because of the lack of witnesses and difficulties in recognizing the signs and the culprit. Targeting risk factors could be a clue to improve these statistics and the prognosis of the disease.Potential risk factors for severe HVA in the European population are basal serum tryptase (BST) above 8âµg, mast cell disorders, the absence of skin symptoms, and cardiovascular conditions requiring the use of beta blockers and ACE inhibitors. Identifying these criteria, mainly based on clinical patterns, helps to develop personalized strategies for management and prevention. SUMMARY: With a personalized medicine approach, phenotypes must be characterized to adapt to the management of patients suffering from Hymenoptera venom anaphylaxis (HVA), including venom immunotherapy (VIT). In this systematic review, all articles mentioned systemic reactions with heterogeneous severity degrees. Half of those reported grade III-IV systemic reactions (Ring and Messmer). HVA clinical patterns could be worsened by one Hymenoptera sting, a patient's history with mast cell disorders, or cardiovascular diseases. VIT failure was attributed to bee venom extract and monotherapy in two-thirds of publications. Findings stress the difficulty of having uniform epidemiological data on HVA and the lack of financial support in some world regions to support appropriate management of these conditions. Although observing a heterogeneity of data, we were able to identify potential risk factors, in particular for the severe cases. We believe our work will support allergists and health professionals to implement improved personalized management of patients suffering from severe HVA.
Subject(s)
Anaphylaxis , Arthropod Venoms , Hymenoptera , Insect Bites and Stings , Humans , Anaphylaxis/prevention & control , Anaphylaxis/epidemiology , Anaphylaxis/therapy , Animals , Hymenoptera/immunology , Insect Bites and Stings/immunology , Insect Bites and Stings/complications , Insect Bites and Stings/epidemiology , Arthropod Venoms/immunology , Arthropod Venoms/adverse effects , Risk Factors , Desensitization, Immunologic/methods , Tryptases/blood , Evidence-Based Medicine , Precision Medicine/methodsABSTRACT
Hematopoietic stem cell transplantation is a curative treatment for many malignant and nonmalignant diseases in children and adults. It is performed with peripheral blood stem cells, bone marrow, and umbilical cord blood. Anaphylaxis may occur during hematopoietic stem cell transplantation, similar to that shown with blood transfusions. In children, although a few cases of anaphylaxis have been reported with cord blood transplantation, no cases of anaphylaxis have been reported with other hematopoietic stem cell transplantations. In this case report, we present the cases of 2 children, one diagnosed with thalassemia major and the other with aplastic anemia, both of whom developed anaphylaxis associated with bone marrow transplantation products cryopreserved with dimethyl sulfoxide and hydroxyethyl starch. Hematopoietic stem cell transplantation-induced anaphylaxis could be associated with cryoprotective agents, especially dimethyl sulfoxide, and alloantigens. In both anaphy-lactic reactions, dimethyl sulfoxide was thought to be the trigger, but it could not be excluded that it was related to stem cell components, plasma, or hydroxyethyl starch.
Subject(s)
Anaphylaxis , Dimethyl Sulfoxide , Hematopoietic Stem Cell Transplantation , Humans , Anaphylaxis/diagnosis , Anaphylaxis/therapy , Anaphylaxis/etiology , Anaphylaxis/immunology , Hematopoietic Stem Cell Transplantation/adverse effects , Male , Dimethyl Sulfoxide/adverse effects , Female , Anemia, Aplastic/therapy , Anemia, Aplastic/immunology , Anemia, Aplastic/diagnosis , beta-Thalassemia/therapy , beta-Thalassemia/immunology , beta-Thalassemia/complications , beta-Thalassemia/diagnosis , Cryoprotective Agents/adverse effects , Cryopreservation , Treatment Outcome , Transplantation, Homologous , Child , Hydroxyethyl Starch Derivatives/adverse effects , Child, PreschoolABSTRACT
In this review, we compare different refractory anaphylaxis (RA) management guidelines focusing on cardiovascular involvement and best practice recommendations, discuss postulated pathogenic mechanisms underlining RA and highlight knowledge gaps and research priorities. There is a paucity of data supporting existing management guidelines. Therapeutic recommendations include the need for the timely administration of appropriate doses of aggressive fluid resuscitation and intravenous (IV) adrenaline in RA. The preferred second-line vasopressor (noradrenaline, vasopressin, metaraminol and dopamine) is unknown. Most guidelines recommend IV glucagon for patients on beta-blockers, despite a lack of evidence. The use of methylene blue or extracorporeal life support (ECLS) is also suggested as rescue therapy. Despite recent advances in understanding the pathogenesis of anaphylaxis, the factors that lead to a lack of response to the initial adrenaline and thus RA are unclear. Genetic factors, such as deficiency in platelet activating factor-acetyl hydrolase or hereditary alpha-tryptasaemia, mastocytosis may modulate reaction severity or response to treatment. Further research into the underlying pathophysiology of RA may help define potential new therapeutic approaches and reduce the morbidity and mortality of anaphylaxis.
Subject(s)
Anaphylaxis , Practice Guidelines as Topic , Humans , Anaphylaxis/therapy , Anaphylaxis/diagnosis , Anaphylaxis/drug therapy , Anaphylaxis/etiology , Disease Management , Epinephrine/therapeutic use , Vasoconstrictor Agents/therapeutic useABSTRACT
PURPOSE OF REVIEW: Perioperative hypersensitivity reactions are rare but potentially catastrophic events. This review acts to summarize recent recommendations for both immediate and poststabilization management of suspected reactions, alongside practical advice for anaesthetists who may be faced with these events. RECENT FINDINGS: Prompt treatment is essential but may be hampered by delay in recognition. This can occur because there are multiple differential diagnoses for the observed clinical signs as well as variations in clinical presentation. Resuscitation is dependent on the use of adrenaline and fluids. Adrenaline should be administered in small, titrated intravenous boluses. Low-dose infusions should be commenced early if the response to boluses is poor. Large volume fluid resuscitation may be required to maintain adequate circulating volume. Chest compressions are recommended when there is evidence of inadequate perfusion, rather than waiting until cardiac arrest is confirmed. Antihistamines and corticosteroids are no longer recommended in the immediate management phase. Once the patient has been stabilized, it is important to obtain serial tryptase concentrations to aid the subsequent clinic investigation. The decision to proceed or abandon surgery will be based on an individual risk-benefit analysis. All cases of suspected perioperative hypersensitivity, including fatal cases, must be referred for formal investigation. SUMMARY: There have been recent updates to management guidelines in perioperative hypersensitivity. Treatment algorithms, treatment packs and referral packs can all help the anaesthetist manage these complex cases, aid the subsequent investigation and ensure patient safety in the future.
Subject(s)
Epinephrine , Humans , Epinephrine/therapeutic use , Epinephrine/administration & dosage , Perioperative Period , Anaphylaxis/therapy , Anaphylaxis/diagnosis , Practice Guidelines as Topic , Hypersensitivity/therapy , Hypersensitivity/diagnosis , Adrenal Cortex Hormones/therapeutic use , Adrenal Cortex Hormones/administration & dosage , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/therapyABSTRACT
For the first time 15 years ago, tablet allergen immunotherapy (T-AIT) formulations were approved by regulatory agencies for treating allergic rhinitis caused by grass pollen in adults and children aged >5 years. Extensive evidences existed about effectiveness and safety of AIT. However, the safety profile is particularly compelling in children. Generally, T-AIT causes local reactions, mostly in the oral cavity, that are usually mild-to-moderate and often self-resolving. However, systemic allergic reactions are also observed with T-AIT, anaphylaxis representing the most fearsome adverse event, considering that it occurs in subjects treated for allergic rhinitis. Therefore, we conducted a literature search of patients reporting anaphylaxis because of T-AIT. Nine cases of anaphylactic reactions were reported in literature. Notably, no death was reported using T-AIT. This outcome was very important as it underscored the substantial safety of T-AIT. However, T-AIT deserves careful attention, mainly in the pediatric population. In this regard, after the first report of anaphylactic reaction at the first administration of T-AIT, manufacturers recommended that the first dose should be administered in a medical facility in the presence of staff with experience in managing anaphylaxis and the patient should be observed for at least 30 min. Interestingly, reported anaphylactic reactions were due to grass pollen extracts, with no report concerning other allergen extracts. However, it is relevant to note that anaphylactic reactions because of T-AIT are not reported in recent years.
Subject(s)
Allergens , Anaphylaxis , Desensitization, Immunologic , Tablets , Humans , Anaphylaxis/therapy , Anaphylaxis/etiology , Anaphylaxis/immunology , Desensitization, Immunologic/methods , Desensitization, Immunologic/adverse effects , Allergens/immunology , Allergens/administration & dosage , Allergens/adverse effects , Child , Pollen/immunology , Pollen/adverse effects , Poaceae/immunology , Poaceae/adverse effects , Rhinitis, Allergic, Seasonal/therapy , Rhinitis, Allergic, Seasonal/immunology , Adult , Rhinitis, Allergic/therapy , Rhinitis, Allergic/immunology , Child, PreschoolSubject(s)
Anaphylaxis , Emergency Service, Hospital , Anaphylaxis/epidemiology , Anaphylaxis/therapy , Humans , Child , Male , Female , Child, Preschool , Adolescent , Disease Management , Patient Education as TopicABSTRACT
BACKGROUND: Anaphylaxis proportions of incidence are increasing globally. However, limited data are available regarding anaphylaxis in the pediatric population of Greece. PURPOSE: The aim of the study was to evaluate management of anaphylaxis in Greek pediatric departments. METHODS: We performed a questionnaire-based study of children aged less than 16 years presenting with anaphylaxis in 10 national pediatric hospitals over a period of 2 years. Management of anaphylaxis was assessed prior to and after an informative intervention. RESULTS: In all, 127 cases of anaphylaxis were identified. Epinephrine was administered in almost half of all cases (51.2%), predominantly through intramuscular route (88.5%), while the majority of anaphylaxis patients were treated with antihistamines (92.9%) and corticosteroids (70.1%). Epinephrine was more likely administered by physicians if the elicitor was a drug (P < 0.003). Regarding long-term management, an epinephrine auto-injector was prescribed in 66.9% of patients. Follow-up information was available for most of the patients (92.9%), the majority of whom (76.3%) were referred to an allergist. More than half of these patients (63.6%) had a documented allergy follow-up, which identified a causative allergen in 53.3% of cases. No statistically significant differences were recorded prior to and after the intervention regarding management of anaphylaxis. CONCLUSIONS: This nationwide study highlighted the necessity of further improvement in terms of anaphylaxis treatment and secondary prevention measures. This presupposes appropriate education and training of healthcare professionals, thus contributing to proper and comprehensive care of the pediatric population.
Subject(s)
Anaphylaxis , Epinephrine , Humans , Anaphylaxis/epidemiology , Anaphylaxis/drug therapy , Anaphylaxis/therapy , Anaphylaxis/diagnosis , Greece/epidemiology , Child , Male , Female , Epinephrine/administration & dosage , Epinephrine/therapeutic use , Child, Preschool , Adolescent , Infant , Surveys and Questionnaires , Histamine Antagonists/therapeutic use , Histamine Antagonists/administration & dosage , Adrenal Cortex Hormones/therapeutic use , Adrenal Cortex Hormones/administration & dosage , Injections, IntramuscularABSTRACT
Delayed anaphylaxis after ingestion of red meat because of galactose-alpha-1,3-galactose (alpha-gal) syndrome has increased in recent years. The mechanism involves an immunoglobulin E reaction to alpha-gal, a molecule found in mammalian meat, dairy products, medications and excipients containing mammalian-derived components, and tick salivary glycans. Sensitization occurs due to the bite of a lone star tick and the transmission of alpha-gal molecules into person's bloodstream. We describe a case of alpha-gal syndrome with severe food, drug, and perioperative allergy in which anaphylaxis with hypovolemic shock occurred immediately after an emergency surgical procedure, when a gelatin-containing drug was injected. This case study confirms that the clinical manifestations of alpha-gal syndrome could be different depending on the route of administration, with immediate reactions if an alpha-gal-containing drug is injected and delayed type allergic manifestations occurring several hours after oral intake. The purpose of this report is to highlight the importance of risk communication in case of exposure to medical products and surgical procedures of patients with alpha-gal syndrome and to encourage drug manufacturers to indicate clearly the origin of excipients in product literature.
Subject(s)
Anaphylaxis , Food Hypersensitivity , Shock , Humans , Anaphylaxis/diagnosis , Anaphylaxis/therapy , Anaphylaxis/etiology , Food Hypersensitivity/diagnosis , Food Hypersensitivity/complications , Food Hypersensitivity/immunology , Shock/etiology , Shock/diagnosis , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/therapy , Male , Animals , Immunoglobulin E/immunology , Excipients/adverse effects , Disaccharides/immunology , Disaccharides/adverse effects , Female , Trisaccharides/immunology , Gelatin/adverse effects , SyndromeABSTRACT
Stinging insects are a frequent cause of local and systemic hypersensitivity reactions, including anaphylaxis. For those with a history of life-threatening anaphylaxis, venom immunotherapy is effective, safe, and can be life-saving. Arachnids are a much less common source of envenomation through bites or stings and are less likely to cause a hypersensitivity reaction. However, recognizing the clinical manifestations when they do present is important for accurate diagnosis and treatment, and, when indicated, consideration of other diagnoses.
Subject(s)
Anaphylaxis , Insect Bites and Stings , Humans , Insect Bites and Stings/complications , Anaphylaxis/therapy , Anaphylaxis/diagnosis , Anaphylaxis/etiology , Animals , Hypersensitivity/therapy , Hypersensitivity/diagnosis , Arthropod Venoms/immunology , Arthropod Venoms/adverse effects , Desensitization, Immunologic/methods , Venom HypersensitivityABSTRACT
BACKGROUND: Anaphylaxis can lead to a life-threatening situation. Therefore, rapid diagnosis and emergency treatment is indicated. Immediate treatment with intramuscular adrenaline (or intravascularly with sufficient medical expertise) in anaphylaxis with cardiovascular and/or respiratory symptoms is recommended by various guidelines. Previous studies have shown that anaphylaxis is often not treated according to guidelines and that adrenaline in particular is rarely administered. OBJECTIVE: The aim of the study was to investigate the data on emergency treatment and outcomes of patients with anaphylaxis by the air rescue and ground-based emergency services Dresden. Moreover, the results of the air- and ground-based services were compared. The focus was on administration of adrenaline and outcomes. MATERIALS AND METHODS: Data from the ground-based emergency service Dresden (from 2012 to 2016) and the air rescue service Dresden (from 2008 to 2015) related to anaphylactic reactions were analyzed retrospectively. The severity of the anaphylaxis, the emergency medication administered, further monitoring, and outcomes were analyzed. RESULTS: Data from 152 adults/29 children were analyzed for air rescue and 1131 adults/223 children for the ground-based emergency service. Adults with grade II-IV anaphylaxis received adrenaline in 19% (air rescue) and 7% (ground rescue) of cases. Children with grade II-IV anaphylaxis received adrenaline in 7% (air rescue) and 8% (ground rescue) of cases. Immediate drug therapy led to an improvement in general condition in 96-98% (air rescue) and 72-77% (ground-based emergency service) of cases. A significant correlation was found between the administration of adrenaline and the improvement in outcome in the ground-based emergency cohort. CONCLUSION: Guideline-compliant first-line therapy with adrenaline was not performed in the majority of the cases analyzed in this study. The significant effect of adrenaline on outcome demonstrated in this study emphases the need to improve the emergency treatment of anaphylactic reactions.
Subject(s)
Anaphylaxis , Emergency Medical Services , Epinephrine , Anaphylaxis/therapy , Anaphylaxis/diagnosis , Anaphylaxis/drug therapy , Anaphylaxis/epidemiology , Humans , Epinephrine/administration & dosage , Epinephrine/therapeutic use , Male , Female , Treatment Outcome , Adult , Child , Middle Aged , Adolescent , Germany , Young Adult , Child, Preschool , Aged , Infant , Air Ambulances/statistics & numerical data , Aged, 80 and over , Retrospective Studies , PrevalenceABSTRACT
Perioperative anaphylaxis is a potentially life-threatening emergency that requires prompt recognition and institution of life-saving therapy. The Australian and New Zealand College of Anaesthetists and Australian and New Zealand Anaesthetic Allergy Group have partnered to develop the anaphylaxis management guideline along with crisis management cards that are recommended for use in suspected anaphylaxis in the perioperative setting. This is the third version of these guidelines with the second version having been published in 2016. This article contains the revised Australian and New Zealand Anaesthetic Allergy Group/Australian and New Zealand College of Anaesthetists perioperative anaphylaxis management guideline, with a brief review of the current evidence for the management of anaphylaxis in the perioperative environment.
Subject(s)
Anaphylaxis , Anaphylaxis/therapy , Humans , New Zealand , Australia , Anesthetists , Perioperative Care/methodsABSTRACT
BACKGROUND: Egg is the third most common food allergy in children; however, data on pediatric egg-induced anaphylaxis are sparse. OBJECTIVE: To describe the clinical characteristics, management, and outcomes of pediatric egg-induced anaphylaxis. METHODS: Children presenting with anaphylaxis were recruited from 13 emergency departments as part of the Cross-Canada Anaphylaxis Registry, from which data on anaphylaxis triggered by egg were extracted. Multivariate logistic regression was used to determine factors associated with prehospital epinephrine autoinjector (EAI) use and to compare anaphylaxis triggered by egg with other triggers of food-induced anaphylaxis (FIA). RESULTS: We recruited 302 children with egg-induced anaphylaxis. The mean age was 2.6 years (SD = 3.6), and 55.3% were male. Only 39.4% had previously been diagnosed with an egg allergy. Prehospital EAI use was 32.1%, but this was not significantly lower than in other triggers of FIA (P = .26). Only 1.4% of patients required hospital admission. Relative to other triggers of FIA, patients with egg-induced anaphylaxis were significantly younger (P < .001) and exhibited more vomiting (P = .0053) and less throat tightness (P = .0015) and angioedema (P < .001). CONCLUSION: To the best of our knowledge, this is the largest published cohort of pediatric egg-induced anaphylaxis. In this cohort, prehospital EAI use was very low. In addition, we identified certain symptoms that distinguish egg-induced from other triggers of FIA. Taken together, high suspicion is crucial in identifying egg-induced anaphylaxis, given the younger patient demographic and frequent lack of FIA history.
Subject(s)
Anaphylaxis , Egg Hypersensitivity , Epinephrine , Humans , Anaphylaxis/drug therapy , Anaphylaxis/etiology , Anaphylaxis/diagnosis , Anaphylaxis/therapy , Male , Female , Cross-Sectional Studies , Egg Hypersensitivity/therapy , Egg Hypersensitivity/diagnosis , Egg Hypersensitivity/immunology , Egg Hypersensitivity/complications , Child, Preschool , Child , Epinephrine/therapeutic use , Epinephrine/administration & dosage , Infant , Canada/epidemiology , Emergency Service, Hospital/statistics & numerical data , RegistriesSubject(s)
Anaphylaxis , Sugammadex , Humans , Sugammadex/adverse effects , Anaphylaxis/chemically induced , Anaphylaxis/diagnosis , Anaphylaxis/therapy , Anaphylaxis/drug therapy , Neuromuscular Nondepolarizing Agents/adverse effects , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/therapy , Drug Hypersensitivity/etiology , Neuromuscular Blockade/adverse effects , Risk FactorsABSTRACT
BACKGROUND: The epidemiology and management of anaphylaxis are not well-reported in Asia. METHODS: A regional pediatric anaphylaxis registry was established by the Asia-Pacific Research Network for Anaphylaxis (APRA), using standardized protocols for prospective data collection, to evaluate the triggers and management of anaphylaxis in the Asia-Pacific region. Pediatric patients below 18 years presenting with anaphylaxis across four Asian countries/cities (Thailand, Singapore, Hong Kong (HK), and Qingdao) were included. Allergen triggers, symptoms, anaphylaxis severity, and management were compared. RESULTS: Between 2019 and 2022, 721 anaphylaxis episodes in 689 patients from 16 centers were identified. The mean age at anaphylaxis presentation was 7.0 years (SD = 5.2) and 60% were male. Food was the most common trigger (62%), particularly eggs and cow's milk in children aged 3 years and below. In school-age children, nut anaphylaxis was most common in HK and Singapore, but was rare in the other countries, and wheat was the top allergen in Bangkok. Shellfish anaphylaxis was most common in children aged 7-17. Adrenaline was administered in 60% of cases, with 9% given adrenaline before hospital arrival. Adrenaline devices were prescribed in up to 82% of cases in Thailand but none in Qingdao. CONCLUSIONS: The APRA identified food as the main trigger of anaphylaxis in children, but causative allergens differed even across Asian countries. Fewer than two-thirds of cases received adrenaline treatment, pre-hospital adrenaline usage was low, and adrenaline device prescription remained suboptimal. The registry recognizes an unmet need to strengthen anaphylaxis care and research in Asia-Pacific.
Subject(s)
Anaphylaxis , Humans , Anaphylaxis/epidemiology , Anaphylaxis/etiology , Anaphylaxis/therapy , Child , Male , Female , Child, Preschool , Asia/epidemiology , Adolescent , Food Hypersensitivity/epidemiology , Food Hypersensitivity/therapy , Infant , Allergens/immunology , Disease Management , Epinephrine/therapeutic use , Epinephrine/administration & dosage , RegistriesABSTRACT
PURPOSE OF REVIEW: Food allergy is a growing health problem that affects both patients and society in multiple ways. Despite the emergence of novel diagnostic tools, such as component-resolved diagnostics (CRD) and basophil activation tests (BAT), oral food challenge (OFC) still plays an indispensable role in the management of food allergies. This review aimed to highlight the indications and safety concerns of conducting an OFC and to provide insights into post-OFC management based on recent findings. RECENT FINDINGS: Standardized OFC protocols have regional diversification, especially in Japan and Western countries. Recent studies suggested that the interval between doses should be at least more than an hour. Furthermore, applying a stepwise method tailored to the patient's specific immunoglobulin E level and history of anaphylaxis seems to mitigate these risks. Recent surveys have shown that, following a positive OFC, options other than strict avoidance are also selected. SUMMARY: OFC serves diverse purposes, yet the risks it carries warrant caution. The stepwise protocol appears promising for its safety. Subthreshold consumption following OFC shows potential; however, further research on its efficacy and safety is required. Management following OFC should be tailored and well discussed between clinicians and patients.
Subject(s)
Allergens , Food Hypersensitivity , Humans , Food Hypersensitivity/immunology , Food Hypersensitivity/therapy , Food Hypersensitivity/diagnosis , Administration, Oral , Allergens/immunology , Allergens/administration & dosage , Anaphylaxis/immunology , Anaphylaxis/diagnosis , Anaphylaxis/prevention & control , Anaphylaxis/therapy , Immunoglobulin E/immunology , Immunoglobulin E/blood , Food/adverse effectsABSTRACT
Background: Anaphylaxis is known as an acute, severe hypersensitivity reaction that rapidly initiates after exposure to a triggering agent. It is a life-threatening condition, and early recognition and swift intervention are crucial to saving patients' lives. Objective: The objective of this study is to assess the ability of certified non-critical care physicians to recognize, manage, and dispose cases of anaphylaxis. Methods: A survey consisting of 19 questions was developed by expert emergency consultants to evaluate physicians' knowledge regarding the recognition, management, and disposition of anaphylactic episodes. Responses were collected through in-person surveys conducted with physicians from various specialties and varying clinical experience levels at a tertiary care center in the Eastern Province of Saudi Arabia. Results: In this cross-sectional study, a total of 173 physicians completed the survey, with 81.5% being consultants and 18.5% specialists. Only 5.2% correctly identified all three proposed anaphylaxis clinical scenarios, 16.8% identified two scenarios correctly, and 51.4% identified only one scenario. While 42.8% recognized the first-line management of anaphylaxis, only 24.3% and 24.9% knew the correct epinephrine dose and route, respectively. Regarding the disposition of patients experiencing an anaphylactic episode, 61.9% of responders opted to dispose the case to the emergency department. Conclusion: Our study reveals a knowledge gap among non-critical care physicians practicing in a tertiary care center concerning the identification and management of anaphylaxis. Raising awareness of this life-threatening condition is imperative to address this serious issue.